U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies-Reference-Cited by-同舟云学术

U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies

Published:2019-04-22 Issue:5 Volume:21 Page:640-650
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Smith Molly A.,Choudhary Gaurav S.^ORCID,Pellagatti Andrea,Choi Kwangmin,Bolanos Lyndsey C.,Bhagat Tushar D.,Gordon-Mitchell Shanisha,Von Ahrens Dagny,Pradhan Kith,Steeples Violetta,Kim Sanghyun,Steidl Ulrich^ORCID,Walter Matthew,Fraser Iain D. C.,Kulkarni Aishwarya,Salomonis Nathan,Komurov Kakajan^ORCID,Boultwood Jacqueline^ORCID,Verma Amit^ORCID,Starczynowski Daniel T.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/s41556-019-0314-5.pdf

Reference57 articles.

1. Vitting-Seerup, K. & Sandelin, A. The landscape of isoform switches in human cancers. Mol. Cancer Res. 15, 1206–1220 (2017).

2. Inoue, D., Bradley, R. K. & Abdel-Wahab, O. Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis. Genes Dev. 30, 989–1001 (2016).

3. Kim, E. et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell 27, 617–630 (2015).

4. Zhang, J. et al. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proc. Natl Acad. Sci. USA 112, E4726–E4734 (2015).

5. Saez, B., Walter, M. J. & Graubert, T. A. Splicing factor gene mutations in hematologic malignancies. Blood 129, 1260–1269 (2017).

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow;eLife;2024-09-05

2. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow;eLife;2024-09-05

3. Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer;Acta Pharmaceutica Sinica B;2024-09

4. Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow;2024-08-21

5. Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia;Biomedicines;2024-08-06